Johnson & Johnson vaccine: CDC panel votes 10-4 to lift suspension amid blood clot concerns

A committee with the U.S. Centers for Disease Control and Prevention on Friday recommended resuming the use of Johnson & Johnson’s COVID-19 vaccine, despite a very rare risk of blood clots.